NVYTF Financials: Novacyt S.A. AI Analysis

Home

Stock

NVYTF

Financials

NVYTF Financial

Novacyt S.A.

$0.48

At close: Mar 24, 16:00:00 GMT-4

$0.48

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.48

Open

$0.48

Day's Range

$0.48 - $0.48

52 week range

$0.48 - $0.641

Volume

350

Avg.Volume

Dividend yield

EPS (TTM)

-0.55

Market Cap

$33.9M

What is NOVACYT?

Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

NVYTF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	19	19	10	21	92	277
Revenue Growth (YoY)	12%	90%	-52%	-77%	-67%	2,418%
Cost of Revenue	7	-12	7	15	64	65
Gross Profit	12	32	3	5	28	211
Selling, General & Admin	22	36	10	13	20	33
Research & Development	3	2	2	5	4	1
Operating Expenses	25	46	17	19	26	36
Other Non Operating Income (Expenses)	0	1	1	1	0	0
Pretax Income	-28	-39	-24	-20	-5	165
Income Tax Expense	0	0	0	2	0	32
Net Income	-30	-41	-28	-25	-9	132
Net Income Growth	-19%	46%	12%	178%	-107%	-2,740%
Shares Outstanding (Diluted)	70.46	70.62	70.62	70.62	70.62	68.18
Shares Change (YoY)	0%	0%	0%	0%	4%	49%
EPS (Diluted)	-0.43	-0.59	-0.4	-0.36	-0.13	1.94
EPS Growth	-19%	48%	11%	177%	-107%	-1,718%
Free Cash Flow	-7	-11	-26	-14	11	101
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	63.15%	168.42%	30%	23.8%	30.43%	76.17%
Operating Margin	-68.42%	-73.68%	-140%	-66.66%	1.08%	62.81%
Profit Margin	-157.89%	-215.78%	-280%	-119.04%	-9.78%	47.65%
Free Cash Flow Margin	-36.84%	-57.89%	-260%	-66.66%	11.95%	36.46%
EBITDA	--	-7	-5	-7	8	182
EBITDA Margin	--	-36.84%	-50%	-33.33%	8.69%	65.7%
D&A For EBITDA	--	7	9	7	7	8
EBIT	-13	-14	-14	-14	1	174
EBIT Margin	-68.42%	-73.68%	-140%	-66.66%	1.08%	62.81%
Effective Tax Rate	0%	0%	0%	-10%	0%	19.39%

Follow-Up Questions

What are Novacyt S.A.'s key financial statements?



According to the latest financial statement (Form-10K), Novacyt S.A. has a total asset of $70, Net loss of $-41

What are the key financial ratios for NVYTF?



Novacyt S.A.'s Current ratio is 3.18, has a Net margin is -215.78, sales per share of $0.26.

How is Novacyt S.A.'s revenue broken down by segment or geography?



Novacyt S.A. largest revenue segment is Yourgene Health, at a revenue of 18,055,145 in the most earnings release.For geography, Asia-Pacific is the primary market for Novacyt S.A., at a revenue of 6,048,308.

Is Novacyt S.A. profitable?



no, according to the latest financial statements, Novacyt S.A. has a net loss of $-41

Does Novacyt S.A. have any liabilities?



yes, Novacyt S.A. has liability of 22

How many outstanding shares for Novacyt S.A.?



Novacyt S.A. has a total outstanding shares of 70.54

Novacyt S.A. (NVYTF) Financial

NVYTF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NOVACYT?

NVYTF Income

Follow-Up Questions

What are Novacyt S.A.'s key financial statements?

What are the key financial ratios for NVYTF?

How is Novacyt S.A.'s revenue broken down by segment or geography?

Is Novacyt S.A. profitable?

Does Novacyt S.A. have any liabilities?

How many outstanding shares for Novacyt S.A.?